L'Oncopole en 2 minutes
L'IUCT-Oncopole en vidéo
About us
Specializing in rare and complex diseases, the IUCT Oncopole treats all patients requiring care for the following diseases : hematological cancers, women's cancers, ENT cancers, skin cancers (melanomas), certain sarcomas, urologic diseases (medical, innovative surgery).
The Institute has all the oncological specialties required to detect, treat and monitor disease: surgery, medicine, radiotherapy and brachytherapy, nuclear medicine, interventional imaging, biology and anatomical pathology. Management of diseases is based on a multidisciplinary approach ensuring care quality: patient records are discussed and studied at weekly meetings attended by physicians from different specialties. All patients therefore enjoy a personalized treatment program, the result of cooperation between different specialists.
Physicians and researchers work on innovative therapeutic programs on a daily basis. The Institute has made high-technology platforms available to them for optimal management, promptly taking into account the most recent advances whether diagnostic or therapeutic.
The IUCT Oncopole is part of the public oncology group located at the following sites : IUCT Oncopole, Purpan IUCT and Rangueil-Larrey IUCT.
The three sites themselves are part of a regional treatment network grouping together 39 public and private health institutions, the IUCT coordinated by Oncomip.
Treatment
- 10 000 new patients per year
- 80 000 appointments per year
- 2500 patients treated by radiotherapy annually
- 306 beds and places
- 7 accelerators
- 7 operating theaters, including 1 dedicated to R&D.
Research
- 2130 publications
- 13% of patients are included in clinical research protocols.
- 21 basic research teams from Toulouse Oncology Research Center
- An INCa-designated early-phase clinical trial center (CLIPP), part of the leading 3 national centers developing phase I trials.